Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Transformative Chemistry - Innovative Products |
Driving next-gen Biosensing and Diagnostics



Bullboard - Investor Discussion Forum Gemina Laboratories Ltd. C.GLAB

Alternate Symbol(s):  GLABF

Healthcare Diagnostics & Research
Gemina Laboratories Ltd. is a Canada-based biosensor and diagnostic company with a transformative, patented, proprietary chemistry that powers testing platforms for a range of pathogens that affect human health and wellness. The Company operates in the in vitro diagnostics (IVD) and human wellness monitoring market under the name Gemina Labs. Its development pipeline includes platforms for the... see more

Bullboard (CSE:GLAB)

View:
Be the first to post on this bullboard.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with C.GLAB

Visit X Visit Linked In Visit Youtube



TECHNOLOGY CORPORATE PRESENTATION NEWS OVERVIEW PRODUCTS MANAGEMENT

Investor Presentation

View the Presentation

Investment Opportunity

Delivering transformative chemistries that will redefine the future of the $43B POC diagnostics industry

  • Patent Portfolio: 34 inventions backed by patent applications.
     
  • Cost-Saving Breakthrough: Dramatic reduction in antibody use, forecasting $3B industry savings.
     
  • First Commercial License (2024): Achieved landmark commercial license, enabling worldwide distribution of Gemina’s technology (100s of millions units/year).
     
  • Commercial Expansion: Negotiating several similar licenses
     


Gemina Laboratories - Antibody Savings on Lateral Flow Assay

more...

Contact Us